Day: December 9, 2022
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
DEVRO PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position held/dealing...
Just Energy Announces Delisting and Trading Halt Dates for Common Shares
Written by Customer Service on . Posted in Public Companies.
TORONTO, Dec. 09, 2022 (GLOBE NEWSWIRE) — Just Energy Group Inc. (“Just Energy” or the “Company”) (NEX:JE.H; OTC:JENGQ), a retail provider specializing in electricity and natural gas commodities and bringing energy efficient solutions and renewable energy options to customers, announces that, effective at the close of business on Thursday, December 15, 2022, its common shares will be delisted from trading on the NEX board of the TSX Venture Exchange (“NEX”) for failure to maintain exchange requirements due to the anticipated closing of the Transaction (as described below).
As previously announced by the Company on December 1, 2022, trading in the common shares will be halted to facilitate the delisting of the common shares. This halt will become effective at the close of trading on Monday, December 12, 2022 and will remain in effect...
BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross proceeds
Written by Customer Service on . Posted in Public Companies.
BBS-Bioactive Bone Substitutes Oyj, Company Announcement, 9 December 2022 at 2.15 p.m. EET
BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross proceeds
The subscription period for BBS-Bioactive Bone Substitutes Oyj’s first series of warrants 1-2022 (WA1) ended on 2 December 2022. In total, 231,415 warrants 1-2022 (WA1) were used, corresponding to approximately 69.0 percent of the total number of warrants. BBS-Bioactive Bone Substitutes Oyj received approximately EUR 213 000 in gross proceeds before expenses. The company’s Board of Directors has today approved the share subscriptions.
The subscription price was EUR 0.92 and SEK 10.10 per share. The subscription period for the shares was 21 November – 2 December 2022.
The shares are expected...
Clean Motion signs distribution agreement for Italy with X-Raam Srl.
Written by Customer Service on . Posted in Public Companies.
Clean Motion has signed a four-year-long distribution agreement with X-Raam Srl. for the Italian market. The agreement refers to EVIG, Clean Motion’s new electric delivery vehicle. This means that X-Raam is responsible for sales, distribution, and aftermarket in Italy. The distributor’s sales forecast for next year is 200 vehicles, but it only commits to a volume of 50 vehicles. For the entire contract period, 2023-2026, they commit to 650 vehicles.
The electric vehicle distributor X-Raam, with a dealer network in Italy, now has EVIG in its portfolio. X-Raam has a forecast of 200 vehicles as early as 2023 and has therefore signed a 4-year-long distribution agreement for EVIG. As part of this, X-Raam has committed to purchase at least 50 EVIG in 2023 and 600 EVIG in 2024–2026.
Alberto Fiorini, General Manager at X-Raam, “Growth...
Avista posts updated Corporate Responsibility report
Written by Customer Service on . Posted in Public Companies.
Visit avistacorp.com for latest environmental, social and governance (ESG) information
SPOKANE, Wash., Dec. 09, 2022 (GLOBE NEWSWIRE) — Today, Avista (NYSE: AVA) published its latest Corporate Responsibility report and other environmental, social and governance (ESG) information on its corporate website, avistacorp.com. The content reports on Avista’s operations and includes commitments in four areas: environment, people, customers and communities, and ethical governance.
The latest updates include Avista’s aspirational goals for workplace Equity, Inclusion and Diversity, an aspirational goal related to Supplier Diversity, and the publication of Avista’s current Equal Employment Opportunity (EEO) 2021 Employer Information Report EEO-1 Consolidated Report. The website also provides links to Avista’s continued reporting on a series...
Form 8.3 – K3 Capital Group Plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
Jupiter Fund Management Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
K3 Capital Group Plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date dealing undertaken: For an opening position disclosure,...
Form 8.3 – AXA INVESTMENT MANAGERS: K3 Capital Group plc.
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
AXA Investment Managers S.A.(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
K3 Capital Group plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position...
Johnson Outdoors Reports Fiscal 2022 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
RACINE, Wis., Dec. 09, 2022 (GLOBE NEWSWIRE) — Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor recreation equipment and technology, today announced slightly lower sales and decreased earnings for the fiscal year ending September 30, 2022. Fiscal 2022 sales fell 1 percent compared to the previous record-high fiscal year, while operating profit decreased 40 percent and net income fell 47 percent over the prior fiscal year.
“While fiscal 2022 sales remained relatively flat compared to fiscal 2021, which was one of our strongest fiscal years, the challenging supply chain situation, primarily in our Fishing business, resulted in significant impact to our profitability. The fiscal fourth quarter showed some easing of supply availability, and we continue to focus on evaluating options to address increased...
Extraordinary general meeting in IDEX Biometrics held on 9 December 2022
Written by Customer Service on . Posted in Public Companies.
IDEX Biometrics ASA held an extraordinary general meeting on 9 December 2022. 376.8 million shares or 34% of the capital was represented at the meeting.
All resolutions were passed as proposed in the notice of the meeting.
The general meeting resolved to issue the Tranche 2 shares of the private placement disclosed on 16 November 2022. 48,745,135 new shares will be issued at NOK 1.00 per share. Following the issue of the Tranche 2 shares, the company’s share capital is NOK 174,948,987.60 divided into 1,166,326.584 shares each with a nominal value of NOK 0.15.
The minutes of the meeting will be available at the company’s web site, www.idexbiometrics.com, in due course.
For further information contact:Marianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.comTel: + 47 9180 0186
About IDEX BiometricsIDEX Biometrics ASA (OSE:...
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
Written by Customer Service on . Posted in Public Companies.
Conference Call Scheduled for December 15, 2022 at 11:00 am EASTERN
DUBLIN, Ireland, Dec. 09, 2022 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2022 on Thursday, December 15, 2022. The Company has scheduled a conference call for that same day, December 15, 2022 at 11:00am ET (16:00pm GMT) to discuss the results of the quarter.Interested parties can access the call by dialing:US Toll Free:
1-844-861-5499International Toll:
1-412-317-6581Ireland Toll:
014311269Ireland Toll Free:
1800932830Please ask to be joined into the Trinity Biotech call.A simultaneous webcast of the call can be accessed at:https://event.choruscall.com/mediaframe/webcast.html?webcastid=XpdogyA1A...